Worldwide COPD and Asthma Diagnostic and Monitoring Devices Industry to 2027 - Daily Exposure to Environmental Pollution is Driving Growth

News provided by

Jun 21, 2021, 16:45 ET

DUBLIN, June 21, 2021 /PRNewswire/ -- The "COPD and Asthma Diagnostic and Monitoring Devices Market by Product, Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

The global COPD and asthma diagnostic and monitoring device market accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to 2027.

Rise in lifestyle habits such as smoking & consumption of alcohol and growth in geriatric population are expected to boost the market growth. In addition, technological advances for new devices, regulatory approvals, and product launches are further promoting the market growth. In addition, prevalence of air pollution, climate changes, and dust fuels the market growth. Moreover, prevalence of respiratory diseases is increasing across the globe. In 2017, according to the WHO, respiratory diseases were considered to be the leading causes of death and disability in the world. Nearly 65 million people suffer from COPD and 3 million are expected to die from it each year, making it the third leading cause of death across the globe.

Moreover, approximately 334 million people suffer from asthma, the most common chronic disease of childhood, affecting 14% of all children globally. Rise in disposable income and increase in healthcare investments by governments & private organizations are anticipated to propel the market growth.

Factors such as rise in prevalence of respiratory diseases, huge demand for enhanced portable devices, growth in geriatric population, and high prevalence of tobacco smoking are expected to drive the market growth during the forecast period. The market is witnessing the emerging trend for spirometers, electrocardiogram, peak flow meter, polysomnography devices, and arterial blood gas analyzer, which is helping in providing real-time monitoring.

The global COPD and asthma diagnostics and monitoring devices market is segmented on the basis of product, indication, end user, and region. Based on the product, the market is segmented into diagnostic devices, monitoring devices, and consumables and accessories. Furthermore, the diagnostic devices segment includes spirometers electrocardiogram, FeNo test analyzer, peak flow meter, arterial blood gas analyzer (ABG), polysomnography devices, and others. The monitoring devices segment includes pulse oximeters, capnograph, asthma monitors, portable table top pulse oximeter, wearable devices, Fourier transform infrared spectroscopy (FTIR), and others.

The consumables and accessories segment includes masks, spirometry accessories, polysomnography accessories, peak flow meter accessories, pulse oximeter sensors, capnography accessories, gas analyzer accessories, and others. Based on indication, the market is divided into asthma and COPD. Based on end user, it is segregated into hospitals & clinics, home care settings, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of respective countries.

The key players operating in the global COPD and asthma diagnostic and monitoring device market include Becton Dickinson and Company, Dragerwerk AG & CO. KGAA, Getinge AB, Invacare Corporation, Masimo Corporation, Medtronic Plc, Koninklijke Philips N.V, Nihon Kohden Corporation, Smiths Medical, and Vyaire Medical INC.

Key Benefits

The study provides an in-depth analysis of the global COPD and asthma diagnostics and monitoring devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the forms and types of cell therapy used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.1.1. Top winning strategies, 2019
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Key forces shaping global COPD and asthma diagnostic and monitoring device market industry/market
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Daily exposure to environmental pollution
3.4.1.2. Increase in population susceptible to indoor air pollutants
3.4.1.3. Portability of the drug delivery devices
3.4.1.4. Increase in population of active smokers
3.4.1.5. Growth in number of surgeries
3.4.2. Restraints
3.4.2.1. High costs of the device
3.4.2.2. Stringent regulatory procedures
3.4.3. Opportunities
3.4.3.1. High growth potential in emerging markets
3.4.3.2. Increase in geriatric population
3.4.4. Impact analysis
3.5. COVID-19 impact analysis for the COPD and asthma diagnostic and monitoring device market
3.6. Volume and average sales price analysis of India and China of COPD and asthma diagnostic and monitoring device market

CHAPTER 4: COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Diagnostic devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market share analysis, by country
4.2.3.1. Market size and forecast, by type
4.2.3.2. Spirometers
4.2.3.3. Market size and forecast
4.2.3.4. Electrocardiogram
4.2.3.5. Market size and forecast
4.2.3.6. FeNo test analyzer
4.2.3.7. Market size and forecast
4.2.3.8. Arterial blood gas analyzer (ABG)
4.2.3.9. Market size and forecast
4.2.3.10. Polysomnography devices
4.2.3.11. Market size and forecast
4.2.3.12. Peak flow meters
4.2.3.13. Market size and forecast
4.2.3.14. Others
4.2.3.15. Market size and forecast
4.3. Monitoring devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country
4.3.3.1. Market size and forecast, by type
4.3.3.2. Pulse oximeters
4.3.3.3. Market size and forecast
4.3.3.4. Capnographs
4.3.3.5. Market size and forecast
4.3.3.6. Asthma monitors
4.3.3.7. Market size and forecast
4.3.3.8. Portable table top pulse oximeter
4.3.3.9. Market size and forecast
4.3.3.10. Wearable devices
4.3.3.11. Market size and forecast
4.3.3.12. Fourier transform infrared spectroscopy (FTIR)
4.3.3.13. Market size and forecast
4.3.3.14. Others
4.3.3.15. Market size and forecast
4.4. Consumables and accessories
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country
4.4.3.1. Market size and forecast, by type
4.4.3.2. Masks
4.4.3.3. Market size and forecast
4.4.3.4. Spirometry accessories
4.4.3.5. Market size and forecast
4.4.3.6. Polysomnography accessories
4.4.3.7. Market size and forecast
4.4.3.8. Peak flow meter accessories
4.4.3.9. Market size and forecast
4.4.3.10. Pulse oximeter sensors
4.4.3.11. Market size and forecast
4.4.3.12. Capnography accessories
4.4.3.13. Market size and forecast
4.4.3.14. Gas analyzer accessories
4.4.3.15. Market size and forecast
4.4.3.16. Others
4.4.3.17. Market size and forecast

CHAPTER 5: COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Asthma
5.2.1. Market size and forecast
5.2.2. Market share analysis, by country
5.3. COPD
5.3.1. Market size and forecast
5.3.2. Market share analysis, by country

CHAPTER 6: COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals and clinics
6.2.1. Market size and forecast
6.2.2. Market share analysis, by country
6.3. Home care settings
6.3.1. Market size and forecast
6.3.2. Market share analysis, by country
6.4. Others
6.4.1. Market size and forecast
6.4.2. Market share analysis, by country

CHAPTER 7: COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES
8.1. BECTON DICKINSON AND COMPANY
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. DRAGERWERK AG & CO. KGAA
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. GETINGE AB
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. INVACARE CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. MASIMO CORPORATION
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC
8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Product portfolio
8.6.4. Business performance
8.7. NIHON KOHDEN CORPORATION
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. KONINKLIJKE PHILIPS N. V.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. SMITHS MEDICAL
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. VYAIRE MEDICAL
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments

For more information about this report visit https://www.researchandmarkets.com/r/c2o81k

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets